Featured Articles

The Motley Fool

Saturday, June 03, 2023, 07:45 AM

Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade

Vertex Pharmaceuticals' main franchise has no competition, and it boasts several promising programs. DexCom's opportunities in the continuous glucose monitoring market make it an attractive long-term pick.